SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-060674
Filing Date
2021-12-20
Accepted
2021-12-20 08:07:20
Documents
13
Period of Report
2021-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ubx-8k_20211217.htm   iXBRL 8-K 33973
2 EX-10.1 ubx-ex101_6.htm EX-10.1 10225
  Complete submission text file 0001564590-21-060674.txt   176842

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ubx-20211217.xsd EX-101.SCH 5706
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20211217_lab.xml EX-101.LAB 19323
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20211217_pre.xml EX-101.PRE 11499
7 EXTRACTED XBRL INSTANCE DOCUMENT ubx-8k_20211217_htm.xml XML 3557
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 211503696
SIC: 2834 Pharmaceutical Preparations